SLC2A6
(Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 6 (SLC2A6))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-SLC2A6 antibody (Catalog #: ARP43973_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
SLC2A6
(Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 6 (SLC2A6))
Synonymes
A330096C23 Peptide, F630103L12Rik Peptide, Glut6 Peptide, Glut9 Peptide, glut6 Peptide, glut9 Peptide, MGC82056 Peptide, SLC2A6 Peptide, si:dkey-104n9.2 Peptide, GLUT6 Peptide, GLUT9 Peptide, HSA011372 Peptide, solute carrier family 2 (facilitated glucose transporter), member 6 Peptide, solute carrier family 2 member 6 Peptide, solute carrier family 2 (facilitated glucose transporter), member 6 L homeolog Peptide, Slc2a6 Peptide, SLC2A6 Peptide, slc2a6.L Peptide, slc2a6 Peptide
Sujet
Hexose transport into mammalian cells is catalyzed by a family of membrane proteins, including SLC2A6, which contains 12 transmembrane domains and a number of critical conserved residues.Hexose transport into mammalian cells is catalyzed by a family of membrane proteins, including SLC2A6, that contain 12 transmembrane domains and a number of critical conserved residues.[supplied by OMIM].